Abstract
Objectives
Primary:
To describe outcomes of all patients started on the national MDR-TB treatment protocol in Matsapha & Mankayane by the MSF Manzini Project, Swaziland since its inception in 2011.
Secondary:
To identify any difference in outcomes between HIV-co-infected and non-co-infected MDR-TB patients.
To identify risk factors associated with poor outcomes (loss to follow up, treatment failure and death).
To evaluate time to culture conversion.
To evaluate time to poor outcomes (loss to follow up, treatment failure and death).
